Trials / Completed
CompletedNCT03945708
Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?
Does Whole Blood Adsorber During CPB Reduce the Amount of Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery? -a Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Emma Hansson · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to investigate the effect of addition of an adsorber during cardio pulmonary bypassin patients with infective endocarditis undergoing valve surgery, and if it will decrease the use of vasoactive drugs postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CytoSorb | Addition of a hemofilter to the cardiopulmonary bypass circuit |
Timeline
- Start date
- 2019-05-15
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-05-10
- Last updated
- 2021-09-22
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03945708. Inclusion in this directory is not an endorsement.